Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
life sciences
medicaid
3
×
national
national blog main
national top stories
pfizer
3
×
aldeyra therapeutics
alzheimer's disease
biogen
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
brammer bio
bristol-myers squibb
cancer
celgene
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
johnson & johnson
new york blog main
new york top stories
novartis
precision biosciences
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
What
alzheimer’s
bio
drug
gene
roundup
access
aducanumab
advanced
amyloid
angst
bagged
billions
biogen
biogen’s
brammer
capacity
car
cell
companies
consolidation
crispr
different
effects
fail
failure
falcon
felt
focus
increases
latest
lost
milestones
nash
news
patient
pharmaceutical
plan
powered
prescription
price
Language
unset
Current search:
medicaid
×
pfizer
×
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More